Skip to content

Other, net at other companies

InfuSystem Holdings logo
InfuSystem HoldingsINFU
$6.15M-68.0%
Baxter International logo
Baxter InternationalBAX
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Medtronic logo
MedtronicMDT
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$4.7B+5.2%
Gross profit$2.2B+15.7%
Operating income$93.0M-75.7%
Net income-$311.0M-201%
EPS (diluted)-$1.11-204%

Balance sheet

See full
Cash & equivalents$1.0B+49.0%
Total debt$14.7B-16.8%
Total equity$24.1B-4.4%
Total assets$50.8B-6.7%

Cash flow

See full
Operating cash flow$671.0M
CapEx$125.0M+9.6%
Free cash flow$546.0M

Valuation

See full
Market cap$41.7B-10.6%
Enterprise value$55.39B-12.5%
P/E36.6×+7.2×
P/S-0.3×

Profitability

See full
Gross margin46.8%+2.5pp
Operating margin10.4%+0.1pp
Net margin5.3%-2.1pp
FCF margin16.4%

Returns & leverage

See full
Return on equity4.6%-1.3pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The official record: Becton, Dickinson and Company’s 10-Q, filed February 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Becton, Dickinson and Company's other, net?
Becton, Dickinson and Company (BDX) reported other, net of -$69M in Q4 2025.
How has Becton, Dickinson and Company's other, net changed year-over-year?
Becton, Dickinson and Company's other, net increased by 9.2% year-over-year, from -$76M to -$69M.
What is the long-term trend for Becton, Dickinson and Company's other, net?
Over 4 years (2021 to 2025), Becton, Dickinson and Company's other, net has grown at a -24.3% compound annual growth rate (CAGR), from -$265M to -$87M.
What does other, net mean?
Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.